Tag: Patient Care

Bench to Bedside: The Research Journey of Fecal Microbiota Transplants

Researchers have known that microorganisms in the gut can impact the effectiveness of immunogenic chemotherapies for cancer patients. When studies showed that the same could be true for immune checkpoint inhibitors, it opened the possibility for better treatment options for

Tagged with: ,

Leadership in Head and Neck Cancer

Head and neck cancer accounts for approximately 4% of cancer cases in the U.S. — affecting more than 60,000 people each year. The majority of those diagnosed are over the age of 50, but a rising rate of HPV-associated head

Tagged with: ,